News
Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...
We're covering the myriad ways GLP-1 weight loss drugs are changing people's lives. (Photo illustration: Yahoo News; photos: ...
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...
Roughly one in three preteens and teens ages 12 to 17 in the United States had prediabetes in 2023, according to new data ...
A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...
GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...
Eli Lilly's biggest growth driver, tirzepatide, will continue facing scrutiny from investors and analysts. The company's oral ...
(1276.HK; 600276.SH) delivered a piece of good news for investors with positive trial data for a dual-acting obesity drug ...
What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...
Tirzepatide yielded greater cardiometabolic benefits, especially in total cholesterol, LDL cholesterol, and weight loss, among women than men.
Tirzepatide may confer larger increases in testosterone levels among men with metabolic hypogonadism than testosterone ...
GLP-1 blockbusters like semaglutide and tirzepatide are widely used for diabetes and weight loss but come with some nasty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results